APA (7th ed.) Citation

Coussy, F., El Botty, R., Lavigne, M., Gu, C., Fuhrmann, L., Briaux, A., . . . Bieche, I. (2020). Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. Journal of Hematology & Oncology, 13(1), 1. https://doi.org/10.1186/s13045-020-0846-y

Chicago Style (17th ed.) Citation

Coussy, F., et al. "Combination of PI3K and MEK Inhibitors Yields Durable Remission in PDX Models of PIK3CA-mutated Metaplastic Breast Cancers." Journal of Hematology & Oncology 13, no. 1 (2020): 1. https://doi.org/10.1186/s13045-020-0846-y.

MLA (9th ed.) Citation

Coussy, F., et al. "Combination of PI3K and MEK Inhibitors Yields Durable Remission in PDX Models of PIK3CA-mutated Metaplastic Breast Cancers." Journal of Hematology & Oncology, vol. 13, no. 1, 2020, p. 1, https://doi.org/10.1186/s13045-020-0846-y.